Acetohydroxamate in struvite stones: in vivo study.

Acetohydroxamate in struvite stones: in vivo study. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Acetohydroxamate in struvite stones: in vivo study. Abstract Text:

A Aroldi,G Graziani,C Castelnovo,G Colussi,M Surian,A Mandressi,E Mascheroni,I Pazardjiklian,A Pagano,C Ponticelli,

This report describes the results obtained with a combination of acetohydroxamic acid (AHA) and antibacterial agents in 13 patients with recurrent struvite stones complicated by refractory infections with urease-producing bacteria. Intravenous antibiotic pulses plus oral AHA achieved urine sterilisation in all. Then oral chemotherapy plus AHA was given for a mean period of 10.8 +/- 5.4 months. In four patients, the urine remained sterile, but in all the patients urinary pH remained below 6.4 and urinary NH4+ below 40 mg/dl. Despite the persistence of urea-splitting bacteria, the radiographic data showed an arrest of stone growth during the first year of treatment.

Acetohydroxamate in struvite stones: in vivo study. Publishing Authors By Initials

A Aroldi,G Graziani,C Castelnovo,G Colussi,M Surian,A Mandressi,E Mascheroni,I Pazardjiklian,A Pagano,C Ponticelli,

For similar bacterial infections and mycoses: infection: urinary tract infections research abstracts see: bacterial infections and mycoses: infection: urinary tract infections research

PUBMED ID PMID:

MEDLINE DATE:

Acetohydroxamate in struvite stones: in vivo study. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Proceedings of the European Dialysis and Transplan

VOLUME: 20

Page Numbers: 469-72

Journal Abbreviation:

ISSN: 0071-2736

DAY: 21

MONTH: 02

YEAR: 1983

Acetohydroxamate in struvite stones: in vivo study. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 355210

Acetohydroxamate in struvite stones: in vivo study. Keywords Mesh Terms:

KEYWORDS: Urinary Tract Infections

MESH TERMS: drug therapy

Chemical & Substance for Abstract: Acetohydroxamate in struvite stones: in vivo study. Information

Substance Name: Urease

Registry Number: EC 3.5.1.5

Grant and Affiliation Information for Acetohydroxamate in struvite stones: in vivo study.

AFFILIATION:

Country: ENGLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Proc Eur Dial Transplant Assoc

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Acetohydroxamate in struvite stones: in vivo study Related Publications

• 'Y' connector system for prevention of peritonitis in CAPD: a controlled study.
• A randomized exploratory trial of steroid avoidance in renal transplant patients treated with everolimus and low-dose cyclosporine.
• Acetohydroxamate in struvite stones: in vivo study.
• Acute kidney injury due to deferoxamine in a renal transplant patient.
• Can mTOR inhibitors reduce the risk of late kidney allograft failure?
• Dopamine-frusemide therapy in acute renal failure.
• Functions of Saccharomyces cerevisiae TFIIF during Transcription Start Site Utilization.
• High fluid intake or pharmacological therapy in recurrent stone former patients?
• Letter: Rosette inhibition test and cell-mediated immunity.
• Letter: T lymphocytes in kidney allograft recipients.
• New recommendations in the treatment of Gram-positive bacteraemia in dialysis patients.
• Propranolol and uraemic osteodystrophy.
• Role of proteinuria reduction in the progression of IgA nephropathy.
• Serological and genetic factors in early recurrence of IgA nephropathy after renal transplantation.
• The long-term outcome of 93 patients with proliferative lupus nephritis.
• Thiazide diuretics in renal hypercalciuria.
• Treatment of membranous nephropathy.
• Urinary acidification in renal allografts.
• [HCV-related liver disease in hemodialysis population: Clinical and biochemical characteristic.]